Strategic guidance from
proven professionals

Chuck Poole, B.S.

Director, Nonclinical & Clinical Pharmacology

Mr. Poole is a DMPK scientist with over 30 years of large pharma experience in preclinical study design and dose prediction for First-in-Human studies. As a DMPK scientist, he has technical expertise in ADME, pharmacokinetics, mass spectrometry, and bioanalysis in support of IND filings, and dose selection. In the past, he managed small teams of scientists providing preclinical bioanalytical and ADME program support.

Education 

  • Bachelor of Science, Biochemistry
    • University of Missouri, Columbia, Missouri